Domestic Animal Endocrinology
Volume 37, Issue 4 , Pages 214-226 , November 2009

Improvement in insulin resistance and reduction in plasma inflammatory adipokines after weight loss in obese dogs

  • A.J. German

      Affiliations

    • Department of Veterinary Clinical Sciences, University of Liverpool, Neston, Wirral CH64 7TE, United Kingdom
    • Corresponding Author InformationCorresponding author. Department of Veterinary Clinical Sciences, University of Liverpool, Leahurst Campus, Chester High Road, Neston, Wirral CH64 7TE, United Kingdom. Tel.: +44 151 795 6100; fax: +44 151 795 6101.
    • ,
  • M. Hervera

      Affiliations

    • Hospital Clínic Veterinari UAB, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain
    • ,
  • L. Hunter

      Affiliations

    • Obesity Biology Research Unit, School of Clinical Sciences, University of Liverpool, Liverpool L69 3GA, United Kingdom
    • ,
  • S.L. Holden

      Affiliations

    • Department of Veterinary Clinical Sciences, University of Liverpool, Neston, Wirral CH64 7TE, United Kingdom
    • ,
  • P.J. Morris

      Affiliations

    • WALTHAM Centre for Pet Nutrition, Waltham-on-the-Wolds, Melton Mowbray, LE14 4RT, United Kingdom
    • ,
  • V. Biourge

      Affiliations

    • Royal Canin Research Centre, Aimargues, France
    • ,
  • P. Trayhurn

      Affiliations

    • Obesity Biology Research Unit, School of Clinical Sciences, University of Liverpool, Liverpool L69 3GA, United Kingdom

Received 2 May 2009 ,Revised 3 July 2009 ,Accepted 3 July 2009.

References 

  1. Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635–643
  2. Lund EM, Armstrong PJ, Kirk CA, Klausner JS. Prevalence and risk factors for obesity in adult dogs from private US veterinary practices. Int J Appl Res Vet Med. 2000;4:177–186
  3. German AJ. The growing problem of obesity in dogs and cats. J Nutr. 2006;136:1940S–1946S
  4. Bach JF, Rozanski EA, Bedenice D, et al. Association of expratory airway dysfunction with marked obesity in healthy adult dogs. Am J Vet Res. 2007;68:670–675
  5. Weeth LP, Fascetti AJ, Kass PH, Suter SE, Santos AM, Delaney SJ. Prevalence of obese dogs in a population of dogs with cancer. Am J Vet Res. 2007;68:389–398
  6. Reisin E, Alpert MA. Definition of the metabolic syndrome: current proposals and controversies. Am J Med Sci. 2005;330:269–272
  7. Diabetes UK. Type 2 Diabetes & Obesity. A Heavy Burden. 2005;
  8. Marmor M, Willeberg P, Glickman LT, Priester WA, Cypress RH, Hurvitz AI. Epizootiologic patterns of diabetes mellitus in dogs. Am J Vet Res. 1982;43:465–470
  9. Davison LJ, Herrtage ME, Catchpole B. Study of 253 dogs in the United Kingdom with diabetes mellitus. Vet Rec. 2005;156:467–471
  10. Fall T, Hamlin HH, Hedhammar A, Kämpe O, Egenvall A. Diabetes mellitus in a population of 180,000 insured dogs: incidence, survival, and breed distribution. J Vet Int Med. 2007;21:1209–1216
  11. Hoenig M. Comparative aspects of diabetes mellitus in dogs and cats. Mol Cell Endocrinol. 2002; 197;. 2002;221–229
  12. Rand JS, Fleeman LM, Harrow HA, Appleton DJ, Lederer R. Canine and feline diabetes mellitus: nature or nuture?. J Nutr. 2004;134:2072S–2080S
  13. Catchpole B, Ristic JM, Fleeman LM, Davison LJ. Canine diabetes mellitus: can old dogs teach us new tricks? Diabetologia. 2005;48:1948–1956
  14. Bailhache E, Nguyen P, Krempf M, Siliart B, Magot T, Ouquerram K. Lipoproteins abnormalities in obese insulin-resistant dogs. Metabolism. 2003;52:559–564
  15. Gayet C, Bailhache E, Dumon H, Martin L, Siliart B, Nguyen P. Insulin resistance and changes in plasma concentration of TNFα, IGF1, and NEFA in dogs during weight gain and obesity. J Anim Physiol Anim Nutr. 2004;88:157–165
  16. Gayet C, Leray V, Saito M, Siliart B, Nguyen P. The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor γ target genes in dogs. Brit J Nutr. 2007;98:497–503
  17. Respondek F, Swanson KS, Belsito KR, et al. Short-chain fructooligosaccharides influence insulin sensitivity and gene expression of fat tissue in obese dogs. J Nutr. 2008;138:1712–1718
  18. Larson BT, Lawler DF, Spitznagel EL, Kealy RD. Improved glucose tolerance with lifetime diet restriction favorably affects disease and survival in dogs. J Nutr. 2003;133:2887–2892
  19. Mattheeuws D, Rottiers R, Baeyens D, Vermeulen A. Glucose tolerance and insulin response in obese dogs. J Am Anim Hosp Assoc. 1984;20:287–293
  20. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc. 2001;60:329–339
  21. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand. 2005;84:285–293
  22. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol. 1999;19:972–978
  23. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Brit J Nutr. 2004;92:347–355
  24. Das UN. Is obesity an inflammatory condition?. Nutr. 2001;17:953–966
  25. Trayhurn P. Adipose tissue in obesity—an inflammatory issue. Endocrinology. 2005;146:1003–1005
  26. Phelan S, Wadden TA, Berkowitz RI, et al. Impact of weight loss on the metabolic syndrome. Int J Obes (Lond). 2007;31:1442–1448
  27. Manco M, Fernandez-Real JM, Equitani F, et al. Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab. 2007;92:483–490
  28. Eisele I, Wood IS, German AJ, Hunter L, Trayhurn P. Adipokine gene expression in dog adipose tissues and dog white adipocytes differentiated in primary culture. Hormone Metab Res. 2005;37:474–481
  29. Ryan VH, German AJ, Wood IS, Hunter L, Morris P, Trayhurn P. NGF Gene expression and secretion by canine adipocytes in primary culture: upregulation by the inflammatory mediators LPS and TNF-α. Hormone Metab Res. 2008;40:861–868
  30. German AJ, Holden SL, Bissot T, Hackett RM, Biourge V. Dietary energy restriction and successful weight loss in obese client-owned dogs. J Vet Intern Med. 2007;21:1174–1180
  31. Laflamme D. Development and validation of a body condition score system for dogs. Canine Pract. 1997;22:10–15
  32. Raffan E, Holden SL, Cullingham F, Hackett RM, Rawlings JM, German AJ. Standardized positioning is essential for precise determination of body composition using dual-energy x-ray absorptiometry in dogs. J Nutr. 2006;136:1976S–1978S
  33. Martinez-Subiela S, Tecles F, Ceron JJ. Critical differences of acute phase proteins in canine serum samples. Vet J. 2003;166:233–237
  34. Martinez-Subiela S, Tecles F, Ceron JJ. Evaluation of acute phase protein indexes in dogs with leishmaniasis at diagnosis, during and after short-term treatment. Vet Med (Praha). 2005;50:39–46
  35. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol. 1979;236:E667–E677
  36. DeFronzo RA, Soman V, Sherwin RS, Hendler R, Felig P. Insulin binding to monocytes and insulin action in human obesity starvation and refeeding. J Clin Invest. 1978;62:204–213
  37. Appleton DJ, Rand JS, Sunvold GD. Basal plasma insulin and homeostasis model assessment (HOMA) are indicators of insulin sensitivity in cats. J Fel Med Surg. 2005;7:183–193
  38. Burkholder WJ. Precision and practicality of methods assessing body composition of dogs and cats. Comp Cont Edu Pract Vet. 2001;23:1–10
  39. Jeusette IC, Detilleux J, Shibata H, et al. Effect of chronic obesity and weight loss on plasma ghrelin and leptin concentrations in dog. Res Vet Sci. 2005;79:169–175
  40. Diez M, Michaux C, Jeusette I, Baldwin P, Istasse L, Biourge V. Evolution of blood parameters in experimental obese beagle dogs. J Anim Physiol Anim Nutr. 2004;88:166–171
  41. Hanusch-Enserer U, Cauza E, Spak M, et al. Improvement of Insulin Resistance and Early Atherosclerosis in Patients after Gastric Banding. Obes Res. 2004;12:284–291
  42. Chikamune T, Katamoto H, Nomura K, Ohashi F. Serum lipid and lipoprotein concentrations in obese dogs. J Am Vet Med Assoc. 1998;57:595–598
  43. Bailhache E, Ouguerram K, Gayet C, et al. An insulin-resistant hypertriglyceridaemic normotensive obese dog model: assessment of insulin resistance by the euglycaemic hyperinsulinaemic clamp in combination with the stable isotope technique. J Anim Physiol Anim Nutr. 2003;87:86–95
  44. LeMay DR, LeMay LG, Kluger MJ, D’Alecy LG. Plasma profiles of IL-6 and TNF with fever-inducing doses of lipopolysaccharide in dogs. Am J Physiol. 1990;259:R126–R132
  45. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87–91
  46. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95:2409–2415
  47. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Rel Metab Dis. 1998;22:1145–1158
  48. Mohamed-Ali V, Flower L, Sethi J, et al. beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J Clin Endocrinol Metab. 2001;86:5864–5869
  49. Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces insulin resistance in hepatocytes. Diabetes. 2002;51:3391–3399
  50. Rau S, Kohn B, Richter C, et al. Plasma interleukin-6 response is predictive for severity and mortality in canine systemic inflammatory response syndrome and sepsis. Vet Clin Pathol. 2007;36:253–260
  51. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004;145:2273–2282
  52. Cook DG, Mendall MA, Whincup PH, et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis. 2000;149:139–150
  53. Putz DM, Goldner WS, Bar RS, Haynes WG, Sivitz WI, Adiponectin . C-reactive protein in obesity, type 2 diabetes, and monodrug therapy. Metabolism. 2004;53:1454–1461
  54. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol. 1999;19:972–978
  55. Chiellini C, Bertacca A, Novelli SE, et al. Obesity modulates the expression of haptoglobin in the white adipose tissue via TNFalpha. J Cell Physiol. 2002;190:251–258
  56. do Nascimento CO, Hunter L, Trayhurn P. Regulation of haptoglobin gene expression in 3T3-L1 adipocytes by cytokines, catecholamines, and PPARgamma. Biochem Biophys res Comm. 2004;313:702–708
  57. McLaughlin T, Abbasi F, Lamendola C, et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation. 2002;106:2908–2912
  58. Gerhardt CC, Romero IA, Cancello R, Camoin L, Strosberg AD. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol. 2001;175:81–92
  59. Kim CS, Park HS, Kawada T, et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond). 2006;30:1347–1355
  60. Abbasi F, Chu JW, Lamendola C, et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes. 2004;53:585–590
  61. Ishioka K, Omachi A, Sagawa M, et al. Canine adiponectin: cDNA structure, mRNA expression in adipose tissues and reduced plasma levels in obesity. Res Vet Sci. 2006;80:127–132
  62. Brunson BL, Zhong Q, Clarke KJ, et al. Serum concentrations of adiponectin and characterization of adiponectin protein complexes in dogs. Am J Vet Res. 2007;68:57–62
  63. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endorcrinol. 2003;148:293–300
  64. Ishioka K, Hosoya K, Kitagawa H, et al. Plasma leptin concentration in dogs: Effects of body condition score, age, gender and breed. Res Vet Sci. 2007;82:11–15

PII: S0739-7240(09)00071-X

doi: 10.1016/j.domaniend.2009.07.001

Domestic Animal Endocrinology
Volume 37, Issue 4 , Pages 214-226 , November 2009

Article Tools

* Image Usage & Resolution